Glutathione

Glutathione Proposed as a Carrier, Not Just a Buffer

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

Orlowski and Meister described the gamma-glutamyl cycle in the Proceedings of the National Academy of Sciences in 1970, proposing that its properties fulfil the requirements of an amino acid transport system and that glutathione serves a carrier function within it.

Key facts

Named by
Orlowski & Meister, 1970
Journal
PNAS, November 1970 (PMID 5274454)
Tissue studied
Rat kidney
Proposed role
Amino acid transport
Translocation step
Gamma-glutamyl transpeptidase
Recovery steps
The two ATP-dependent ligases
Later tissue work
Cornell 1976, PNAS (PMID 1755)

What the cycle is

A closed sequence in which glutathione is synthesised, its gamma-glutamyl group transferred to something else, and the components recovered and reassembled. Orlowski and Meister showed rat kidney contains the full set of enzymes for both halves (synthesis and utilisation), which is what makes it a cycle rather than a pathway running one way.

The proposal that reframes the molecule

Their conclusion was that the cycle has properties fulfilling the requirements of an amino acid transport system, and that glutathione serves a carrier function within it. That is a different account of what the molecule is for than antioxidant defence. It makes glutathione a vehicle rather than only a buffer.

Research material referenced

Glutathione 1500mg, third-party HPLC tested

Buy Glutathione · £38.99

How transport would work

Gamma-glutamyl transpeptidase transfers the gamma-glutamyl group from glutathione onto an amino acid, forming a gamma-glutamyl amino acid. Orlowski and Meister proposed that this species is what crosses, with the transpeptidase functioning in translocation. Inside, the amino acid is released and the glutamyl portion recycled.

Why the ATP cost then makes sense

The 1970 abstract names gamma-glutamylcysteine synthetase and glutathione synthetase as catalysing energy-requiring recovery steps in transport. Those are the two ATP-dependent ligases that build glutathione. Active transport requires energy input somewhere, and in this account that is where it enters, so the expense of making glutathione outside a ribosome has a proposed purpose.

What this adds to the gamma bond story

This site already explains that the gamma-glutamyl linkage is why glutathione cannot be made by a ribosome and why proteases largely cannot cleave it. Both are consequences. Orlowski and Meister propose a reason the bond exists at all: a gamma linkage is transferable in a way an alpha peptide bond is not, which is what makes the molecule usable as a handle.

How the account stands now

The cycle itself is established biochemistry and its enzymes are well characterised. How much amino acid transport actually proceeds this way, against other transport systems, has been debated since. The paper's own title says a possible transport system; the hedge was there from the start and should be preserved.

Frequently asked questions

What is the gamma-glutamyl cycle?

A closed sequence in which glutathione is synthesised, its gamma-glutamyl group transferred to another molecule, and the components recovered and reassembled.

What did Orlowski and Meister propose?

That the cycle fulfils the requirements of an amino acid transport system and that glutathione serves a carrier function within it.

Why does the gamma bond matter for that?

A gamma linkage is transferable in a way an alpha peptide bond is not, which is what makes the molecule usable as a handle.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More Glutathione articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.